Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD-Reference-Cited by-同舟云学术

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

Published:2023-02-17 Issue:3 Volume:77 Page:920-930
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Canivet Clémence M.,Costentin Charlotte,Irvine Katharina M.,Delamarre Adèle,Lannes Adrien,Sturm Nathalie,Oberti Frederic,Patel Preya J.,Decaens Thomas,Irles‐Depé Marie,Fouchard Isabelle,Hermabessière Paul,Roux Marine,Barthelon Justine,Calès Paul,Powell Elizabeth E.,de Ledinghen Victor,Boursier Jérôme

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32665

Reference40 articles.

1. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy‐proven NAFLD;J Hepatol,2017

2. Mortality in biopsy‐confirmed nonalcoholic fatty liver disease: results from a nationwide cohort;Gut,2021

3. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis;Hepatology,2017

4. Prospective study of outcomes in adults with nonalcoholic fatty liver disease;N Engl J Med,2021

5. New sequential combinations of non‐invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD;J Hepatol,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel circulating fibroblast activation protein - based predictive model to improve fibrosis risk stratification in metabolic liver disease population;2024-07-22

2. How effective are experienced hepatologists at staging fibrosis using non‐invasive fibrosis tests in patients with metabolic dysfunction‐associated steatotic liver disease?;Alimentary Pharmacology & Therapeutics;2024-06-11

3. MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials;Journal of Internal Medicine;2024-05-13

4. The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD;Obesity;2024-05-03

5. US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening;Radiology;2024-04-01